Dr. Gretchen M Ibele MD

Recommended Articles

• Genetic Advancements in Lymphoma Treatment

  Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Dreams Do Come True: 9-year-old Baseball Fanatic Signed Onto Team

  Like most young baseball fans, John “Parker” Staples' room is covered in memorabilia from his favorite team, the Washington Nationals, but unlike most kids, Parker's room is at the University of Virginia Children's Hospital.John “Parker” Staples, is nine-year old who was diagnosed with...

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...